We hypothesize, that in patients with COPD, SNPs in the IFNL3/4 gene will impact clinical outcomes such as exacerbation and that they might be associated with circulating markers of inflammation and tissue remodelling. The gene discussed is IFNL3; the disease is chronic obstructive pulmonary disease.